PEPGEN INC (PEPG:NASDAQ)
$1.5 -0.02 (-1.3158%)
Analysed PEPGEN INC (PEPG:NASDAQ) News Sources
PepGen Reports Fourth Quarter and Year-End 2025 Financial Results and Recent Corporate Highlights
04-03-2026
yahoo.com
PepGen muscular dystrophy drug gets ‘surprise’ hold from FDA
05-03-2026
biopharmadive.com
PepGen Announces Topline Results from Lowest Dose (5 mg/kg) MAD Cohort in the Ongoing Phase 2 FREEDOM2 Study Demonstrating Favorable Safety, Splicing and vHOT Data
30-03-2026
yahoo.com
PepGen Reports Encouraging Phase II FREEDOM2 DM1 Data at 5 mg/kg; 10 mg/kg Cohort Underway
01-04-2026
marketbeat.com
AstronauTx builds executive team with appointment of experienced clinical development leader Michelle Mellion, MD as Chief Medical Officer
12-05-2026
yahoo.com
PepGen Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
12-05-2026
yahoo.com
PepGen (PEPG) Upgraded to Buy: Here's What You Should Know
13-05-2026
yahoo.com
Is PepGen (PEPG) One of the Best NASDAQ Stocks Under $5 to Buy Right Now?
18-05-2026
yahoo.com
PepGen (PEPG) Loses 14.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
20-05-2026
yahoo.com
PepGen Announces Presentations at the 15th International Myotonic Dystrophy Consortium Highlighting Clinical Data from the PGN-EDODM1 Program
21-05-2026
yahoo.com
What is the current price of PEPGEN INC (PEPG:NASDAQ)?
The current price of PEPGEN INC (PEPG:NASDAQ) is $1.5.
PEPGEN INC (PEPG:NASDAQ) absolute price change since previous trading day?
The absolute price change of PEPGEN INC (PEPG:NASDAQ) since the previous trading day is $-0.02.
PEPGEN INC (PEPG:NASDAQ) percentage price change since previous trading day?
The percentage price change of PEPGEN INC (PEPG:NASDAQ) since the previous trading day is -1.3158%.
What is the most recent average sentiment score for PEPGEN INC (PEPG:NASDAQ)?
The most recent average sentiment score for PEPGEN INC (PEPG:NASDAQ) is 69 out of 100.
What is the most recent average sentiment for PEPGEN INC (PEPG:NASDAQ)?
The most recent sentiment for PEPGEN INC (PEPG:NASDAQ) is .
SEC-8K** Filing Available For PEPGEN INC (PEPG:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.